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Abstract
Accumulating evidence suggests that the glutamatergic system plays a major role in the
pathophysiology of obsessive compulsive disorder (OCD) and empathic processing. Partic-
ularly, genetic influence of glutamate transporter gene (SLC1A1) on OCD has been fre-
quently replicated in previous studies, but several studies did not replicate the result.
Therefore, we aimed to replicate the associations between the SLC1A1 and OCD in a
Korean population. In addition, we investigated the influence of SLC1A1 on trait empathy,
impairments in which are characteristic of OCD. Six single-nucleotide polymorphisms (SNP)
of SLC1A1 were genotyped in 615 patients with OCD and 508 healthy controls. The inter-
personal reactivity index (IRI)—which consists of four subscales (perspective taking, PT;
fantasy seeking, FS; empathic concern, EC; personal distress, PD)—was assessed from
277 patients with OCD and 395 controls. There were no significant associations between
OCD and SNPs or haplotypes of SLC1A1. Patients with OCD exhibited significantly lower
PT and higher PD scores than controls. The C-T-G haplotype at rs301430-rs301434-
rs3087879 of SLC1A1 was significantly associated with higher PD scores after adjusted for
age, sex, and OCD status. Our results suggest that six common SNPs of SLC1A1 may not
contribute to the development of OCD, but may contribute to certain aspect of trait empathy
such as personal distress. However, insufficient sample size and limited number of SLC1A1
SNPs may have reduced the likelihood of detecting significant associations. Therefore, fur-
ther studies with larger sample size and more tag SNPs of the SLC1A1 gene were
warranted.
Introduction
Although the causes of obsessive compulsive disorder (OCD) are not fully understood, accu-
mulating evidence indicates that the underlying bases of OCD are neurochemical [1]. To date,
the serotonin hypothesis is the most prevailing theory regarding the underlying mechanisms
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of OCD [2]. However, approximately 40% of patients with OCD exhibit an inadequate
response to serotonin reuptake inhibitors (SRIs), and functional abnormality of the seroto-
nin system is not always observed in patients with OCD [1]. In addition, research has dem-
onstrated that the serotonin system is closely interrelated with other neurotransmitter
systems in the brain [1], indicating that other neurotransmitters may play a role in the
pathophysiology of OCD. Recently, several lines of evidence have suggested that alterations
in glutamate neurotransmission also contribute to OCD pathophysiology. Magnetic reso-
nance spectroscopy (MRS) studies have implicated dysregulation of glutamate neurotrans-
mission in cortico-striatal-thalamo-cortical circuits in OCD [3]. Additional studies have
reported increased levels of glutamate in the cerebrospinal fluid of patients with OCD [4].
Furthermore, the potential therapeutic benefits of some glutamate modulating agents such
as memantine [5], N-acetyl cysteine, riluzole [6], and ketamine [7] have been demonstrated
in patients with OCD.
Based on the aforementioned evidence, researchers have suggested that genes associated
with glutamate neurotransmission may represent the genetic basis of OCD. Among them,
SLC1A1—which encodes glutamate transporter EAAC1—has received particular attention
because several linkage studies have suggested that the 9p24 region, at which SLC1A1 lies, may
contain a susceptibility gene for OCD [8,9]. To date, several studies have investigated the asso-
ciation between SLC1A1 single nucleotide polymorphisms (SNP) and OCD. Four studies
reported a positive association between SLC1A1 and OCD in single SNP analyses [10–13],
while three additional studies reported a significant association between SLC1A1 and OCD in
haplotype analyses, but not in single SNP analyses [14–16]. However, one study found no sig-
nificant association between two SNPs of SLC1A1 and OCD, although a significant influence
of SNPs on fluoxetine response was observed [17]. A meta-analysis comprising 815 trios, 306
patients with OCD, and 634 controls found no significant influences of SLC1A1 (nine SNPs)
on OCD [18]. These inconsistent findings suggest that additional independent studies are
needed. Moreover, to our knowledge, no study has been conducted using subjects of Korean
descent regarding the relationship between SLC1A1 variants and primary OCD, except for
studies related to antipsychotics-induced obsessive-compulsive symptoms in schizophrenia
[19,20].
Lack of empathy has been regarded as a characteristic trait of OCD [21,22]. Empathy refers
to the ability to understand and share others’ emotional states in reference to oneself [23].
Pino et al. [24] suggested that OCD is associated with deficits in understanding the mental and
emotional states of others and difficulty sharing in the negative emotional experiences of oth-
ers. Other studies have also reported that patients with OCD exhibit higher levels of personal
distress [21,22], empathic concern [21], and lower perspective taking [22] than controls when
trait empathy is measured using the interpersonal reactivity index (IRI). Empathic traits are
highly heritable [25], and several studies have suggested that various genes such as oxytocin
receptor gene (OXTR) [26,27], serotonin receptor gene (HTR2A) [28], or brain-derived neuro-
trophic factor gene (BDNF) [29] influence IRI. Because several MRS studies have suggested
that the glutamatergic system is associated with empathy [30,31], genes associated with gluta-
mate neurotransmission such as SLC1A1 represent potential candidates for genetic markers of
trait empathy.
Therefore, the present study aimed (1) to replicate the association between SLC1A1 and
OCD in a sample of Korean OCD probands and controls, and (2) to determine the influence
of SLC1A1 on trait empathy as measured using the IRI.
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Materials and methods
Participants
A total of 615 (man 398, woman 217; mean age 29.9±10.7) unrelated patients with OCD were
recruited from Yonsei University Severance Hospital. All patients with OCD were diagnosed
using the Structured Clinical Interview and met Axis I criteria specified in the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) [32]. Patients with a lifetime
history of any psychotic symptoms, mental retardation, comorbid alcohol or other substance
use disorders within the last 6 months, or a history of severe organic or neurologic disorders
were excluded. A total of 508 healthy, unrelated individuals (man 286, woman 222; mean age
22.2±2.7) were recruited via community advertisements. All participants were of Korean
descent according to their home language and self-identified as being of Korean descent. The
institutional review board of Severance Hospital approved the study protocol, and written
informed consent was obtained from all participants.
Measurements
The severity of symptoms in patients with OCD were assessed using the Yale-Brown Obses-
sive-Compulsive Scale (Y-BOCS) [33]. The severity of depressive symptoms was assessed
using the Montgomery-Asberg Depression Rating Scale (MADRS) [34]. Trait empathy was
measured using the IRI [35], which contains 28-items scored on a 5-point Likert scale rang-
ing from “Does not describe me well” to “Describes me very well”. The IRI contains four
subscales: (1) Perspective Taking (PT), which measures the tendency to adopt the psycho-
logical viewpoints of others; (2) Fantasy (FS), which measures the tendency to imagine and
identify with fictional characters such as those from books or movies; (3) Empathic Concern
(EC), which measures the tendency to experience "other-oriented" feelings of sympathy and
concern for the misfortune of others; (4) Personal Distress (PD), which measures the ten-
dency to have "self-oriented" feelings of personal anxiety, discomfort, and unease in tense
interpersonal settings [35]. The PD and EC scales assess affective components, whereas the
PT scale assesses cognitive components. We used the Korean version of the IRI in the pres-
ent study [36].
SNP selection and genotyping
Among all variants of SLC1A1, we selected six SNPs (rs2228622, rs3780412, rs301430,
rs301434, rs3087879, rs301443) that have been most frequently examined in previous studies
and often associated with OCD and/or obsessive-compulsive symptoms in single-marker or
haplotype analyses [10–17,19,20,37–40]. Genomic DNA was extracted from blood or saliva.
Genotyping was performed using single-base primer extension assay (ABI PRISM SNaPShot
Multiplex kit, ABI, Foster City, CA).
Statistical analyses
Differences in demographic and clinical data between patients and controls were examined
using Chi-square (χ2) association tests for categorical variables, while t-tests or multivariate
analyses of variance (ANOVA) were used for continuous variables. Differences in the allelic
distribution of the six SLC1A1 SNPs were examined using χ2 tests. Associations between each
SNP genotype and OCD status were examined using age- and sex-adjusted multivariate logis-
tic regression analyses. The genetic model was assumed as additive (i.e., genotypes were coded
as 0, 1, and 2 based on the minor allele count). Single-marker analyses were performed using
the R package SNPassoc [41]. In haplotype analyses, haplotype blocks of the six SLC1A1 SNPs
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were defined based on the ‘solid spine of linkage disequilibrium (LD)’ approach in the control
sample using Haploview v4.0 [42]. Associations between haplotype distributions and OCD
under additive model were examined using the ‘haplo.score’ function of R package haplo.stats
[43], while adjusting for age and sex.
In order to analyze the relationship between SLC1A1 variants and certain aspects of empa-
thy measured with IRI, we used all available IRI data that were collected from both OCD and
control groups. Therefore, we included disease status (affected vs. unaffected) as a covariate, as
well as age and sex, in the analyses of IRI data. The influences of each SNP genotype on the
four subscale scores of IRI were examined by multivariate logistic regression analyses adjusted
for age, sex, and OCD status. The influence of haplotype on each IRI subscale score was exam-
ined using the ‘haplo.score’ function, with adjustment for age, sex, and OCD status.
For single-marker analyses, correction for multiple comparisons of the six SNPs was per-
formed by Bonferroni method. Therefore, the level of statistical significance was set at
p<0.0083 (0.05/6) for single SNP analysis. For haplotype analyses, permutation adjustments
were performed (n = 100,000), and simulated p<0.05 was regarded as significant.
The statistical power necessary to identify an association with OCD in the present study
was calculated as 84.1–99.7% using Quanto software (version 1.2.4; http://biostats.usc.edu/
software), based on the minor allele frequency, a genotype relative risk of 1.5 under the
assumption of a log-additive model, and a disease prevalence of 2% [44,45].
Results
Demographic and clinical characteristics
The demographic and clinical characteristics of patients with OCD and controls are listed in
Table 1. Patients with OCD were significantly older (t = 17.29, p<0.001) and more frequently
male (χ2 = 8.28, p = 0.002) than controls. Therefore, we used age and sex as covariates in subse-
quent analyses. The IRI was assessed from 277 patients with OCD and 395 controls. Patients
with OCD exhibited significantly lower PT (F = 5.37, p = 0.02) and higher PD (F = 103.18,
p<0.001) scores on the IRI than controls.
Association between SLC1A1 SNPs and OCD status
No SNP data deviated from Hardy–Weinberg equilibrium in the control group (S1 Table).
There were no significant associations between allele/genotype of the six SNPs and OCD status
(Table 2). In haplotype analyses, two haplotype blocks were identified: block 1 (rs2228622,
rs3780412) and block 2 (rs301430, rs301434, rs3087879) (S1 Fig). There were no significant
differences in the distribution of block 1 or block 2 haplotype frequencies between the OCD
and control groups (Table 3). Considering that significantly different sex ratios between the
two groups might have influenced results, we repeated these analyses in male and in female
samples separately. However, the results remained unchanged (S2–S5 Tables).
Influences of SLC1A1 SNPs on IRI
In single SNP analyses, nominally significant associations were observed between rs301443
and PT (p = 0.046), rs3780412 and FS (p = 0.044), rs2228622 and PD (p = 0.034), and
rs3780412 and PD (p = 0.016) (S6–S9 Tables). However, the significance of these associations
disappeared after adjusting for multiple comparisons. In haplotype analyses, the C-T-G haplo-
type in block 2 (rs301430-rs301434-rs3087879) was significantly associated with higher PD
scores (Hap-score = 2.0427, crude p = 0.0411, simulated p = 0.0419) (Table 4). However, none
of the remaining haplotypes in blocks 1 and 2 exhibited any associations with PT, FS, or EC
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scores on the IRI (S10–S12 Tables). When the single-marker and haplotype analyses were
repeated separately for male and female participants, the association between C-T-G haplotype
in block 2 and PD score was no longer significant (data not shown).
Table 2. Distribution of allelic and genotypic frequencies of SLC1A1 SNPs between OCD and controls.
Allele Genotype
rs number D/da OCDb Controlb p-valuec OCDd Controld OR add
(95% CI)
p-valuee
rs2228622 G/A 910/314 781/233 0.1426 337/236/39 300/181/26 1.08 (0.86–1.35) 0.5130
rs3780412 T/C 901/327 768/242 0.1491 331/239/44 293/182/30 1.08(0.87–1.35) 0.4795
rs301430 C/T 790/434 660/348 0.6454 253/284/75 218/224/62 0.94(0.77–1.14) 0.5208
rs301434 T/C 1104/122 922/92 0.4816 495/114/4 418/86/3 1.08(0.77–1.50) 0.6638
rs3087879 G/C 1080/144 911/103 0.2272 473/134/5 409/93/5 1.02(0.75–1.40) 0.8980
rs301443 C/G 660/568 572/440 0.1888 182/296/136 176/220/110 1.03(0.85–1.24) 0.7869
OCD, obsessive-compulsive disorder; SNP, single nucleotide polymorphism; OR, odds ratio; CI, confidence interval; add, additive.
aLowercase d denotes the less frequent allele.
bNumber of major and minor alleles in individuals with OCD and controls.
cp-values by Pearson’s χ2 test for allelic associations.
dNumber of genotypes in individuals with OCD and controls. Order of genotypes: DD/Dd/dd (d is the minor allele).
ep-values by multivariate logistic regression, with adjustment for age and sex.
https://doi.org/10.1371/journal.pone.0190593.t002
Table 1. Socio-demographic and clinical characteristics of the study sample.
Variable OCD (n = 615) Controls (n = 508) p-value
Age, years 29.93 ± 10.71 22.19 ± 2.67 < 0.001
Male/Female, n 398/217 286/222 0.004
Illness duration, years 11.37 ± 8.33
Y-BOCS score
Total 24.99 ± 6.00
Obsessions 12.68 ± 3.04
Compulsions 12.30 ± 3.47
Basal MADRS score 18.57 ± 8.69
Comorbid diagnosis, n (%)
Major depression 77 (12.5)
Others 85 (13.8)
Symptom dimensions, present, n (%)
Symmetry 476 (77.4)
Forbidden thoughts 549 (89.3)
Cleaning 471 (76.6)
Hoarding 215 (35.0)
Interpersonal Reactivity Indexa (n = 277) (n = 395)
Perspective taking 15.13 ± 4.81 15.63 ± 3.58. 0.021
Fantasy seeking 16.26 ± 4.61 16.80 ± 3.88 0.909
Empathic concern 16.62 ± 4.79 15.84 ± 3.58 0.412
Personal distress 16.64 ± 4.97 13.77 ± 3.22 <0.001
OCD, obsessive-compulsive disorder; Y-BOCS, Yale-Brown obsessive-compulsive scale; MADRS, Montgomery-Åsberg depression rating scale; MDD,
major depressive disorder.
aMultivariate analysis of variance with adjustment of age and sex (Hotelling’s trace; F = 28.36, df = 4, p<0.001).
https://doi.org/10.1371/journal.pone.0190593.t001
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Discussion
In the present study, we identified no significant associations between six SNPs or haplotypes
of SLC1A1 and OCD in a sample of Korean probands and controls. SLC1A1 has received atten-
tion as a promising candidate gene for OCD, as two independent studies have suggested a link-
age between OCD and 9p24, on which SLC1A1 is located [8,9]. Several subsequent association
Table 3. The effects of SLC1A1 haplotype on affected status of OCD.
Block Hap-Freqa Hap-scoreb Crude pc Sim. pd
1 (rs2228622- rs3780412)e
G T 0.7276 -0.9275 0.3537 0.3584
A C 0.2276 0.3112 0.7557 0.7584
G C 0.0244 1.1025 0.2702 0.2779
A T 0.0151 1.5637 0.1179 0.1201
2 (rs301430-rs301434-rs3087879)f
T T G 0.1578 -1.1051 0.2691 0.2725
T C G 0.0846 0.1554 0.8765 0.8774
T T C 0.1045 0.1589 0.8737 0.8759
C C G 0.0102 0.5159 0.6059 0.6138
C T G 0.6285 0.6505 0.5153 0.5195
aHap-Freq, estimated frequency of the haplotype in the pool of all participants.
bHap-Score, score for the haplotype.
cAsymptotic chi-square p-value.
dSimulated p-value.
eGlobal-stat = 4.5776, df = 4, p = 0.3335, global simulated p = 0.3473.
fGlobal-stat = 1.5781, df = 5, p = 0.9039, global simulated p = 0.9077.
https://doi.org/10.1371/journal.pone.0190593.t003
Table 4. The effects of SLC1A1 haplotype on personal distress score of IRI.
Block Hap-Freqa Hap-Scoreb Crude pc Sim. pd
1 (rs2228622- rs3780412)e
G T 0.7259 -2.1945 0.0282 0.0283
A T 0.0137 -0.8380 0.4020 0.4001
G C 0.0234 0.2688 0.7881 0.7869
A C 0.2326 2.3562 0.0185 0.0189
2 (rs301430-rs301434-rs3087879)f
T C G 0.0810 -1.5968 0.1103 0.1105
T T G 0.1538 -1.1870 0.2352 0.2339
T T C 0.0986 0.7831 0.4336 0.4344
C C G 0.0135 1.0641 0.2873 0.2873
C T G 0.6386 2.0427 0.0411 0.0419
IRI, interpersonal reactivity index.
aHap-Freq, estimated frequency of the haplotype in the pool of all subjects.
bHap-Score, score for the haplotype.
cAsymptotic chi-square p-value.
dSimulated p-value.
eGlobal-stat = 6.6530, df = 4, p = 0.1554, global simulated p = 0.1569.
fGlobal-stat = 16.2884, df = 5, p = 0.0061, global simulated p = 0.0063.
https://doi.org/10.1371/journal.pone.0190593.t004
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studies have demonstrated a significant association between SLC1A1 and OCD. A family-
based association study involving 87 patients with early-onset OCD and their parents reported
significant associations of rs3780412, rs301430, and the T-C haplotype at rs301430-rs301979
with OCD (in the whole sample and in men but not in women) [11]. Arnold et al. [10] per-
formed a family-based association study involving 157 patients with OCD and 319 of their
first-degree relatives, reporting significant associations between OCD and rs301434, rs301435,
and rs3087879 SNPs of SLC1A1. The authors of this previous study further reported that the
C-G haplotype of rs301434-rs3087879 was positively associated with OCD in male offspring. A
family-based association study by Stewart et al. [14] involving 66 patients with OCD and their
families further reported that the A-T-T haplotype of rs12682807-rs2072657-rs301430 was sig-
nificantly over-transmitted to offspring with OCD, whereas no single SNPs were associated
with OCD. In addition, Shugart et al. [12] performed a family-based association study of 13
SLC1A1 SNPs in a large sample consisting of 1,950 participants across 378 families (1,006
patients with definite or probable OCD), demonstrating an association between rs301433 and
OCD under the dominant model. Wu et al. [16] conducted a case-control study involving 578
patients with OCD and 649 controls among the Han Chinese population. In their study, the
G-A-C-G and G-G-T-C haplotypes of rs10491734-rs2228622-rs301430-rs301443 were signifi-
cantly associated with OCD, although no differences in the distributions of genotypes or alleles
for individual SNPs were observed between the OCD and control groups.
Despite such evidence, other studies have reported no influence of SLC1A1 on OCD.
Samuels et al. [13] conducted a family-based association study of 111 SNPs in or near SLC1A1.
Although several SNPs and a haplotype were nominally significantly associated with OCD,
those associations were not significant after correction for multiple comparisons. A recent
meta-analysis with 815 trios, 306 patients with OCD, and 634 controls also reported no signifi-
cant association between SLC1A1 (nine SNPs) and OCD [18]. Furthermore, Zhang et al. [17]
found no association between SLC1A1 (rs3780412, rs301430) and OCD (OCD, n = 340 and
control, n = 350). A case-control study involving patients of the Han Chinese population also
reported no association between rs301430 or rs3780412 of SLC1A1 and OCD [17]. Our find-
ings are in accordance with these studies, suggesting a lack of association between SLC1A1
SNPs and OCD. This discrepancy between the positive findings of previous studies and our
results may be due to differences in the genotype distributions of SLC1A1 between individuals
of European descent and those of Korean descent. For example, Stewart et al. [14] reported a
minor allele frequency of 0.43 for rs2228622, whereas this value was 0.23 in the present study
(controls). In addition, most studies reporting a positive association between SLC1A1 and
OCD were family-based design, whereas the present study utilized a case-control design.
Another possible explanation for this discrepancy is that the haplotypes and LD structure of
our study were not identical to those used in previous studies due to differences in the ethnic
background of the sample and genotyped SNPs of SLC1A1. Indeed, the particular SNPs of
SLC1A1 reported to be associated with OCD are not entirely consistent among studies
[10,11,13,14]. Furthermore, in contrast to our study, some previous studies reporting positive
associations utilized less conservative methods of correction (e.g., permutations) [10] or failed
to perform correction for multiple comparisons [11], potentially leading to false-positive asso-
ciations. In addition, such inconsistencies regarding the association between SLC1A1 and
OCD may be due to the underlying genetic heterogeneity of OCD.
In the present study, patients with OCD had significantly lower PT and higher PD scores
than controls, even after adjusting for age and sex. These findings suggested that patients with
OCD exhibit impairments in the ability to spontaneously consider another’s point of view, as
well as emotions in response to observing extreme distress in others [35]. Although we mainly
aimed to compare IRI scores between the OCD and control groups, our findings of lower PT
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and higher PD scores in the OCD group are mostly consistent with those of previous studies
[21,22]. Interestingly, we observed that the C-T-G haplotype at rs301430-rs301434-rs3087879
of SLC1A1 was associated with higher PD scores. To our knowledge, the present study is the
first to report a genetic influence of SLC1A1 on trait empathy as measured using the IRI.
Although no previous studies have examined the association between SLC1A1 and empathy,
several lines of evidence support the involvement of the glutamatergic system in empathy. One
fMRI-MRS study suggested that glutamatergic modulation of emotional processing is critical
for inducing feelings of empathy [30]. Another MRS study reported that glutamate concentra-
tion in the dorsolateral prefrontal cortex is negatively correlated with PT score on the IRI [31].
Two genetic studies have also demonstrated an influence of the SLC1A1 gene on autism,
which is also characterized by a lack of empathy. A family-based association study involving
86 trios with autism suggested that the T-G haplotype at rs301430-rs301979 is negatively asso-
ciated with autism (recessive model) [46], while a subsequent study reported that the C allele
of rs301430 was associated with more severe anxiety in patients with autism spectrum disorder
[47]. One neuroimaging study demonstrated that PD was positively correlated with grey mat-
ter volume of the anterior insula and negatively correlated with that in the somatosensory cor-
tex [48]. Research has indicated that glutamate levels in the anterior insula play a major role in
emotional processing, and that impairments in glutamate transmission within this region are
associated with alexithymia [49]. These findings suggest that SLC1A1 is associated with trait
empathy. However, considering that PD represents affective empathy rather than cognitive
empathy, our finding regarding the association between certain haplotypes of SLC1A1 and PD
may be counterintuitive. Therefore, our results should be regarded as preliminary, as further
large-scale studies are required to draw more definitive conclusions.
Several limitations of the present study should be addressed. First, controls were not
matched with OCD patients in terms of their age and sex. Although the analyses were adjusted
for these demographic factors and reanalysis stratified by sex did not reveal significant sex-spe-
cific associations, the possibility of confounding effect could not be completely excluded. Sec-
ond, while our sample size was relatively larger than those of previous studies that examined
associations between SLC1A1 SNPs and OCD, that statistical power of our study findings may
not be sufficient for detecting significant associations. Particularly, as IRI was only assessed in
a subset of participants, statistical power to find significant relationships between SLC1A1 vari-
ants and IRI scores could have been further reduced and results may have been biased. Hence,
results regarding the associations between SLC1A1 and IRI should be interpreted with caution.
Third, all tag SNPs fully covering the SLC1A1 gene were not included in this study. Although
the variants genotyped in this study have been mostly replicated for their associations with
OCD and/or obsessive-compulsive symptoms in literature, other variants of SLC1A1 may be
associated with OCD and/or trait empathy in a Korean population. Therefore, we could not
draw a clear conclusion regarding the relationship between SLC1A1 and OCD in a Korean
population. Fourth, we did not rule out the possible confounding effects of population sub-
structure, although Korean population is known to be relatively genetically homogeneous.
Nonetheless, although we observed no associations between SNPs of SLC1A1 and OCD in
individuals of Korean descent, our findings indicate that a certain haplotype of SLC1A1 was
associated with PD scores, as measured using the IRI. Further studies involving larger sample
sizes should investigate a larger number SNPs for the SLC1A1 gene.
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S1 Fig. Linkage disequilibrium (LD) patterns and haplotype blocks estimated with markers
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